Sara Elena Rebuzzi

Inflammatory indices and clinical factors in metastatic renal cell carcinoma patients treated with nivolumab: the development of a novel prognostic score (Meet-URO 15 study)

Sara Elena Rebuzzi, Alessio Signori, Giuseppe Luigi Banna et al. · Therapeutic Advances in Medical Oncology · 2021 · 93 citations · Full text

Medicine, Immunology, Oncology +17

EPSILoN: A Prognostic Score Using Clinical and Blood Biomarkers in Advanced Non–Small-cell Lung Cancer Treated With Immunotherapy

Arsela Prelaj, Sara Elena Rebuzzi, Pamela Pizzutilo et al. · Clinical Lung Cancer · 2020 · 80 citations

Medicine, Immunology, Oncology +14

EPSILoN: A Prognostic Score for Immunotherapy in Advanced Non-Small-Cell Lung Cancer: A Validation Cohort

Arsela Prelaj, Roberto Ferrara, Sara Elena Rebuzzi et al. · Cancers · 2019 · 78 citations · Full text

Medicine, Immunology, Oncology +17

The prognostic power of inflammatory indices and clinical factors in metastatic castration-resistant prostate cancer patients treated with radium-223 (BIO-Ra study)

Matteo Bauckneht, Sara Elena Rebuzzi, Alessio Signori et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2021 · 77 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate- or Poor-risk International Metastatic Renal Cell Carcinoma Database Consortium Criteria Treated by Immune-oncology Combinations: Differential Effectiveness by Risk Group?

Matteo Santoni, Sebastiano Buti, Zin Myint et al. · European Urology Oncology · 2023 · 77 citations · Full text

Medicine, Immunology, Oncology +14